Company or ticker...

Roivant Sciences

Roivant builds and funds biotech companies around drug programs.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

ROIV

25.8B

3,300.3

n/a

64.72%

Key Facts

M. Cap

PS

PE

YTD

25.8B

3,300.3

n/a

64.72%

10MA

20MA

50MA

200MA

$ROIV